Cargando…
Establishment of a Human Gastric Cancer Xenograft Model in Immunocompetent Mice Using the Microcarrier-6
Gastric cancer is among the most common malignant tumors of the digestive tract. Establishing a robust and reliable animal model is the foundation for studying the pathogenesis of cancer. The present study established a mouse model of gastric carcinoma by inoculating immunocompetent mice with MKN45...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165317/ https://www.ncbi.nlm.nih.gov/pubmed/32337226 http://dx.doi.org/10.1155/2020/1893434 |
_version_ | 1783523451331411968 |
---|---|
author | Bi, Yanzhen Wang, Quanyi Yang, Yonghong Wang, Quanquan Zhang, Kai Zhang, Xiaobei Cho, William C. Shu, Zhenfeng Li, Jiannan Liu, Lili Si, Chuanping Hong, Feng |
author_facet | Bi, Yanzhen Wang, Quanyi Yang, Yonghong Wang, Quanquan Zhang, Kai Zhang, Xiaobei Cho, William C. Shu, Zhenfeng Li, Jiannan Liu, Lili Si, Chuanping Hong, Feng |
author_sort | Bi, Yanzhen |
collection | PubMed |
description | Gastric cancer is among the most common malignant tumors of the digestive tract. Establishing a robust and reliable animal model is the foundation for studying the pathogenesis of cancer. The present study established a mouse model of gastric carcinoma by inoculating immunocompetent mice with MKN45 cells using microcarrier. Sixty male C57BL/6 mice were randomly divided into three groups: a 2D group, an empty carrier group, and a 3D group, according to the coculture system of MKN45 and the microcarrier. The mouse models were established by hypodermic injection. Time to develop tumor, rate of tumor formation, and pathological features were observed in each group. In the 3D group, the tumorigenesis time was short, while the rate of tumor formation was high (75%). There was no detectable tumor formation in either the 2D or the empty carrier group. Both H&E and immunohistochemical staining of the tumor xenograft showed characteristic evidence of human gastric neoplasms. The present study successfully established a human gastric carcinoma model in immunocompetent mice, which provides a novel and valuable animal model for the cancer research and development of anticancer drugs. |
format | Online Article Text |
id | pubmed-7165317 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-71653172020-04-24 Establishment of a Human Gastric Cancer Xenograft Model in Immunocompetent Mice Using the Microcarrier-6 Bi, Yanzhen Wang, Quanyi Yang, Yonghong Wang, Quanquan Zhang, Kai Zhang, Xiaobei Cho, William C. Shu, Zhenfeng Li, Jiannan Liu, Lili Si, Chuanping Hong, Feng Biomed Res Int Research Article Gastric cancer is among the most common malignant tumors of the digestive tract. Establishing a robust and reliable animal model is the foundation for studying the pathogenesis of cancer. The present study established a mouse model of gastric carcinoma by inoculating immunocompetent mice with MKN45 cells using microcarrier. Sixty male C57BL/6 mice were randomly divided into three groups: a 2D group, an empty carrier group, and a 3D group, according to the coculture system of MKN45 and the microcarrier. The mouse models were established by hypodermic injection. Time to develop tumor, rate of tumor formation, and pathological features were observed in each group. In the 3D group, the tumorigenesis time was short, while the rate of tumor formation was high (75%). There was no detectable tumor formation in either the 2D or the empty carrier group. Both H&E and immunohistochemical staining of the tumor xenograft showed characteristic evidence of human gastric neoplasms. The present study successfully established a human gastric carcinoma model in immunocompetent mice, which provides a novel and valuable animal model for the cancer research and development of anticancer drugs. Hindawi 2020-04-04 /pmc/articles/PMC7165317/ /pubmed/32337226 http://dx.doi.org/10.1155/2020/1893434 Text en Copyright © 2020 Yanzhen Bi et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Bi, Yanzhen Wang, Quanyi Yang, Yonghong Wang, Quanquan Zhang, Kai Zhang, Xiaobei Cho, William C. Shu, Zhenfeng Li, Jiannan Liu, Lili Si, Chuanping Hong, Feng Establishment of a Human Gastric Cancer Xenograft Model in Immunocompetent Mice Using the Microcarrier-6 |
title | Establishment of a Human Gastric Cancer Xenograft Model in Immunocompetent Mice Using the Microcarrier-6 |
title_full | Establishment of a Human Gastric Cancer Xenograft Model in Immunocompetent Mice Using the Microcarrier-6 |
title_fullStr | Establishment of a Human Gastric Cancer Xenograft Model in Immunocompetent Mice Using the Microcarrier-6 |
title_full_unstemmed | Establishment of a Human Gastric Cancer Xenograft Model in Immunocompetent Mice Using the Microcarrier-6 |
title_short | Establishment of a Human Gastric Cancer Xenograft Model in Immunocompetent Mice Using the Microcarrier-6 |
title_sort | establishment of a human gastric cancer xenograft model in immunocompetent mice using the microcarrier-6 |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165317/ https://www.ncbi.nlm.nih.gov/pubmed/32337226 http://dx.doi.org/10.1155/2020/1893434 |
work_keys_str_mv | AT biyanzhen establishmentofahumangastriccancerxenograftmodelinimmunocompetentmiceusingthemicrocarrier6 AT wangquanyi establishmentofahumangastriccancerxenograftmodelinimmunocompetentmiceusingthemicrocarrier6 AT yangyonghong establishmentofahumangastriccancerxenograftmodelinimmunocompetentmiceusingthemicrocarrier6 AT wangquanquan establishmentofahumangastriccancerxenograftmodelinimmunocompetentmiceusingthemicrocarrier6 AT zhangkai establishmentofahumangastriccancerxenograftmodelinimmunocompetentmiceusingthemicrocarrier6 AT zhangxiaobei establishmentofahumangastriccancerxenograftmodelinimmunocompetentmiceusingthemicrocarrier6 AT chowilliamc establishmentofahumangastriccancerxenograftmodelinimmunocompetentmiceusingthemicrocarrier6 AT shuzhenfeng establishmentofahumangastriccancerxenograftmodelinimmunocompetentmiceusingthemicrocarrier6 AT lijiannan establishmentofahumangastriccancerxenograftmodelinimmunocompetentmiceusingthemicrocarrier6 AT liulili establishmentofahumangastriccancerxenograftmodelinimmunocompetentmiceusingthemicrocarrier6 AT sichuanping establishmentofahumangastriccancerxenograftmodelinimmunocompetentmiceusingthemicrocarrier6 AT hongfeng establishmentofahumangastriccancerxenograftmodelinimmunocompetentmiceusingthemicrocarrier6 |